BioPharma
60-Day Window by Trump for Firms to Lower Their...
President Donald Trump of the USA has sent letters to the drug company CEOs demanding they lower their drug prices. The letters that have been...
BioPharma
Canada-UK Partnership Integrates Bioreactor Technologies
In a recent move, an international initiative is going to transform biologics as well as drug manufacturing by way of AI-driven multi-platform integration. The AI-optimized...
BioPharma
Bavarian Nordic Agrees for a $3 Bn Take-Private Offer
Bavarian Nordic, the vaccine maker, on July 28 said that it has agreed in principle for roughly $3 bn take-private offer from private equity firms...
BioPharma
South Korea – A Biopharma Innovation Hub With 113%...
The biopharmaceutical sector of South Korea has seen a growth in innovators and drug licensing agreements by way of reaching a total deal value of...
BioPharma
Vinay Prasad Leaves the FDA – An Abrupt End...
The head of the Food and Drug Administration office, overseeing vaccines and gene therapy, Vinay Prasad leaves the FDA after taking over his job just...
BioPharma
AstraZeneca plans to invest $50 billion in America for...
AstraZeneca announces $50 billion of investment in the United States by 2030, building on America’s global leadership in medicines manufacturing and R&D. This investment is...
BioPharma
AI in Genomics Market – Setting Pace for Vast...
There is no shred of doubt that artificial intelligence in genomics is indeed reshaping the healthcare spectrum, offering unmatched opportunities to decode the intricacies of...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.